<- Go Home
Diaceutics PLC
Diaceutics PLC, a diagnostic commercialization company, provides data, data analytics, and implementation services for pharma and biotech companies. The company offers DXRX, a diagnostic commercialization platform for precision medicine that integrates multiple pipelines of diagnostic testing data from a network of laboratories. It also provides DXRX data solutions, including DXRX Signal, that enables potential therapy eligibility for patients within hours of a diagnostic event, enabling teams to act while treatment decisions are still pending; DXRX Physician Mapping that examines physician testing behavior using patient level data to determine testing rates, methodology, and physician to lab relationship; DXRX Lab Mapping that offers insights into labs currently testing patients diagnosed with a specific disease or biomarker; and DXRX Disease Testing Rate Tracker, which delivers biomarker testing rate reports. In addition, the company offers scientific and advisory services. It operates in North America, the United Kingdom, Europe, Asia, and internationally. The company was incorporated in 2005 and is headquartered in Belfast, the United Kingdom.
Market Cap
GBP 120.2M
Volume
123.2K
Cash and Equivalents
GBP 7.3M
EBITDA
GBP 4.1M
Tax Rate Collected
N/A
Tax Rate Ratio
N/A
Gross Profit
GBP 31.5M
Profit Margin
81.90%
52 Week High
GBP 1.80
52 Week Low
GBP 1.14
Dividend
N/A
Price / Book Value
2.97
Price / Earnings
1.3K
Price / Tangible Book Value
4.93
Enterprise Value
GBP 114.0M
Enterprise Value / EBITDA
26.06
Operating Income
GBP 43.0K
Return on Equity
0.24%
Return on Assets
0.05
Cash and Short Term Investments
GBP 7.3M
Debt
GBP 1.2M
Equity
GBP 40.5M
Revenue
GBP 38.4M
Unlevered FCF
-GBP 4.0M
Sector
Life Sciences Tools and Services
Category
N/A